Scars have always been an issue, and the majority of treatments have failed to address them adequately. The biggest obstacle that plastic surgeons still face is finding an effective procedure that works for all skin types in the long run. In a non-invasive way, external volume expansion (EVE) devices use suction to mechanically stretch and stimulate tissues. Different studies have proposed various mechanisms for how stretch releases the skin, including mechanical action on individual cells, inflammation, ischemia, and soluble mediators that promote cell proliferation, adipogenesis, and most crucially, vascular remodeling. Platelet-rich plasma (PRP) is a product made from autologous blood that is concentrated in plasma volume and contains an abundance of platelets, growth factors, and chemo/cytokines. The contents of the alpha and dense granules in PRP have the ability to provide a high concentration of growth factors to the tissues that need them. Autologous fat grafting, initially described by Neuber in 1893 and subsequently improved by Coleman, is a relatively new alternative to scar tissue removal. It is believed that autologous fat grafting improves skin quality by increasing dermal thickness and volume via stimulating the neosynthesis of collagen fibers. It is still unclear what impact autologous fat grafting has on scar tissue, despite its growing popularity in the medical field, and the use of postoperative cephalosporin is very essential for guarding against infection and losing of fat. Critics have cast doubt on its usefulness due to the fact that survival rates can range from 30% to 80% , the infection rate and loss of fat